Literature DB >> 8526163

Management of the septum during rhinoplasty.

A de la Fuente, J L Martín del Yerro.   

Abstract

Septal deviation is the rule more than the exception in most cases of rhinoplasty. When deviation of the septum precludes a good rhinoplasty's functional and aesthetic results because of impairment of nasal air flow, residual deviation, or inadequate medialitation of the lateral nasal wall, a modified submucous resection of the deviated part is certainly indicated. If possible, a dorsocaudal L-strut of cartilage should be maintained, but, if necessary, it can be resected partially or totally and the support of this area reestablished by dorsal and columellar cartilage grafts. The authors recommend a bilateral mucoperichondrial-mucoperiosteal dissection of the septum from its caudal edge to the most posterior deviated part, because it provides easy septal resection in a good surgical field.

Entities:  

Mesh:

Year:  1995        PMID: 8526163     DOI: 10.1007/bf00453880

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  6 in total

1.  THE DEVIATED NASAL SEPTUM. I. AETIOLOGY.

Authors:  L GRAY
Journal:  J Laryngol Otol       Date:  1965-07       Impact factor: 1.469

2.  An evaluation of post-operative packing in nasal septal surgery.

Authors:  D A Nunez; F W Martin
Journal:  Clin Otolaryngol Allied Sci       Date:  1991-12

3.  Management of the deviated nose. The importance of septal reconstruction.

Authors:  J P Gunter; R J Rohrich
Journal:  Clin Plast Surg       Date:  1988-01       Impact factor: 2.017

Review 4.  Complications of submucous resections of the nasal septum.

Authors:  A Tzadik; S E Gilbert; J Sade
Journal:  Arch Otorhinolaryngol       Date:  1988

5.  The versatile cartilage autograft: current trends in clinical transplantation.

Authors:  B Brent
Journal:  Clin Plast Surg       Date:  1979-04       Impact factor: 2.017

6.  Rhinoseptoplasty.

Authors:  B Vilar-Sancho
Journal:  Aesthetic Plast Surg       Date:  1984       Impact factor: 2.326

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.